APO Research, Inc.

APO RESEARCH · REPORT

Calming Aids for Dogs

Selected research

Industry Research

Calming Aids for Dogs Industry Research Report 2026

Market perspective

The global Calming Aids for Dogs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Calming Aids for Dogs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Calming Aids for Dogs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Calming Aids for Dogs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Calming Aids for Dogs include Zoetis, Shangrao Chunyu Technology, Shandong Youmi Le Health Technology, Zatural, Wild One, Vetoquinol, ThunderEase, This Dog's Life and The Anxious Pet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Calming Aids for Dogs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Calming Aids for Dogs Market by Company

Zoetis

Shangrao Chunyu Technology

Shandong Youmi Le Health Technology

Zatural

Wild One

Vetoquinol

ThunderEase

This Dog's Life

The Anxious Pet

Purina

Primo Pup

PetHonesty

Pet Remedy

Penelope's Bloom

NaturVet

Merck Animal Health

Maxxidog

Kradle

Koi CBD

King Kanine

Heavenly Hounds

FOMO Bones

Extract Labs

ElleVet Sciences

Elanco

Dr. Harvey’s

Ceva

Boehringer Ingelheim

Ark Naturals

Adaptil

Calming Aids for Dogs Segment by Type

Calming Collars

Calming Supplements

Pheromone Sprays

Anxiety Vests

Calming Aids for Dogs Segment by Application

Pet Shop

Pet Hospitals and Clinics

Household

Others

Calming Aids for Dogs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming Aids for Dogs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calming Aids for Dogs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming Aids for Dogs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Calming Aids for Dogs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Calming Aids for Dogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Calming Aids for Dogs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Calming Aids for Dogs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Calming Aids for Dogs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Calming Aids for Dogs Revenue of Manufacturers (2021-2026) Table 9. Global Calming Aids for Dogs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Calming Aids for Dogs Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Calming Aids for Dogs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Calming Aids for Dogs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Calming Aids for Dogs, Product Type & Application Table 14. Global Calming Aids for Dogs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Calming Aids for Dogs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Zoetis Calming Aids for Dogs Product Portfolio Table 22. Zoetis Recent Developments Table 23. Shangrao Chunyu Technology Company Information Table 24. Shangrao Chunyu Technology Business Overview Table 25. Shangrao Chunyu Technology Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio Table 27. Shangrao Chunyu Technology Recent Developments Table 28. Shandong Youmi Le Health Technology Company Information Table 29. Shandong Youmi Le Health Technology Business Overview Table 30. Shandong Youmi Le Health Technology Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio Table 32. Shandong Youmi Le Health Technology Recent Developments Table 33. Zatural Company Information Table 34. Zatural Business Overview Table 35. Zatural Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Zatural Calming Aids for Dogs Product Portfolio Table 37. Zatural Recent Developments Table 38. Wild One Company Information Table 39. Wild One Business Overview Table 40. Wild One Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Wild One Calming Aids for Dogs Product Portfolio Table 42. Wild One Recent Developments Table 43. Vetoquinol Company Information Table 44. Vetoquinol Business Overview Table 45. Vetoquinol Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Vetoquinol Calming Aids for Dogs Product Portfolio Table 47. Vetoquinol Recent Developments Table 48. ThunderEase Company Information Table 49. ThunderEase Business Overview Table 50. ThunderEase Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. ThunderEase Calming Aids for Dogs Product Portfolio Table 52. ThunderEase Recent Developments Table 53. This Dog's Life Company Information Table 54. This Dog's Life Business Overview Table 55. This Dog's Life Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. This Dog's Life Calming Aids for Dogs Product Portfolio Table 57. This Dog's Life Recent Developments Table 58. The Anxious Pet Company Information Table 59. The Anxious Pet Business Overview Table 60. The Anxious Pet Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. The Anxious Pet Calming Aids for Dogs Product Portfolio Table 62. The Anxious Pet Recent Developments Table 63. Purina Company Information Table 64. Purina Business Overview Table 65. Purina Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Purina Calming Aids for Dogs Product Portfolio Table 67. Purina Recent Developments Table 68. Primo Pup Company Information Table 69. Primo Pup Business Overview Table 70. Primo Pup Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Primo Pup Calming Aids for Dogs Product Portfolio Table 72. Primo Pup Recent Developments Table 73. PetHonesty Company Information Table 74. PetHonesty Business Overview Table 75. PetHonesty Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. PetHonesty Calming Aids for Dogs Product Portfolio Table 77. PetHonesty Recent Developments Table 78. Pet Remedy Company Information Table 79. Pet Remedy Business Overview Table 80. Pet Remedy Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Pet Remedy Calming Aids for Dogs Product Portfolio Table 82. Pet Remedy Recent Developments Table 83. Penelope's Bloom Company Information Table 84. Penelope's Bloom Business Overview Table 85. Penelope's Bloom Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Penelope's Bloom Calming Aids for Dogs Product Portfolio Table 87. Penelope's Bloom Recent Developments Table 88. NaturVet Company Information Table 89. NaturVet Business Overview Table 90. NaturVet Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. NaturVet Calming Aids for Dogs Product Portfolio Table 92. NaturVet Recent Developments Table 93. Merck Animal Health Company Information Table 94. Merck Animal Health Business Overview Table 95. Merck Animal Health Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Merck Animal Health Calming Aids for Dogs Product Portfolio Table 97. Merck Animal Health Recent Developments Table 98. Maxxidog Company Information Table 99. Maxxidog Business Overview Table 100. Maxxidog Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Maxxidog Calming Aids for Dogs Product Portfolio Table 102. Maxxidog Recent Developments Table 103. Kradle Company Information Table 104. Kradle Business Overview Table 105. Kradle Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Kradle Calming Aids for Dogs Product Portfolio Table 107. Kradle Recent Developments Table 108. Koi CBD Company Information Table 109. Koi CBD Business Overview Table 110. Koi CBD Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Koi CBD Calming Aids for Dogs Product Portfolio Table 112. Koi CBD Recent Developments Table 113. King Kanine Company Information Table 114. King Kanine Business Overview Table 115. King Kanine Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. King Kanine Calming Aids for Dogs Product Portfolio Table 117. King Kanine Recent Developments Table 118. Heavenly Hounds Company Information Table 119. Heavenly Hounds Business Overview Table 120. Heavenly Hounds Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Heavenly Hounds Calming Aids for Dogs Product Portfolio Table 122. Heavenly Hounds Recent Developments Table 123. FOMO Bones Company Information Table 124. FOMO Bones Business Overview Table 125. FOMO Bones Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. FOMO Bones Calming Aids for Dogs Product Portfolio Table 127. FOMO Bones Recent Developments Table 128. Extract Labs Company Information Table 129. Extract Labs Business Overview Table 130. Extract Labs Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Extract Labs Calming Aids for Dogs Product Portfolio Table 132. Extract Labs Recent Developments Table 133. ElleVet Sciences Company Information Table 134. ElleVet Sciences Business Overview Table 135. ElleVet Sciences Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. ElleVet Sciences Calming Aids for Dogs Product Portfolio Table 137. ElleVet Sciences Recent Developments Table 138. Elanco Company Information Table 139. Elanco Business Overview Table 140. Elanco Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Elanco Calming Aids for Dogs Product Portfolio Table 142. Elanco Recent Developments Table 143. Dr. Harvey’s Company Information Table 144. Dr. Harvey’s Business Overview Table 145. Dr. Harvey’s Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Dr. Harvey’s Calming Aids for Dogs Product Portfolio Table 147. Dr. Harvey’s Recent Developments Table 148. Ceva Company Information Table 149. Ceva Business Overview Table 150. Ceva Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Ceva Calming Aids for Dogs Product Portfolio Table 152. Ceva Recent Developments Table 153. Boehringer Ingelheim Company Information Table 154. Boehringer Ingelheim Business Overview Table 155. Boehringer Ingelheim Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Boehringer Ingelheim Calming Aids for Dogs Product Portfolio Table 157. Boehringer Ingelheim Recent Developments Table 158. Ark Naturals Company Information Table 159. Ark Naturals Business Overview Table 160. Ark Naturals Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Ark Naturals Calming Aids for Dogs Product Portfolio Table 162. Ark Naturals Recent Developments Table 163. Adaptil Company Information Table 164. Adaptil Business Overview Table 165. Adaptil Calming Aids for Dogs Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Adaptil Calming Aids for Dogs Product Portfolio Table 167. Adaptil Recent Developments Table 168. Global Calming Aids for Dogs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 169. Global Calming Aids for Dogs Sales by Region (2021-2026) & (k units) Table 170. Global Calming Aids for Dogs Sales Market Share by Region (2021-2026) Table 171. Global Calming Aids for Dogs Sales by Region (2027-2032) & (k units) Table 172. Global Calming Aids for Dogs Sales Market Share by Region (2027-2032) Table 173. Global Calming Aids for Dogs Revenue by Region (2021-2026) & (US$ Million) Table 174. Global Calming Aids for Dogs Revenue Market Share by Region (2021-2026) Table 175. Global Calming Aids for Dogs Revenue by Region (2027-2032) & (US$ Million) Table 176. Global Calming Aids for Dogs Revenue Market Share by Region (2027-2032) Table 177. North America Calming Aids for Dogs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. North America Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 179. North America Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 180. North America Calming Aids for Dogs Revenue by Country (2021-2026) & (US$ Million) Table 181. North America Calming Aids for Dogs Revenue by Country (2027-2032) & (US$ Million) Table 182. Europe Calming Aids for Dogs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Europe Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 184. Europe Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 185. Europe Calming Aids for Dogs Revenue by Country (2021-2026) & (US$ Million) Table 186. Europe Calming Aids for Dogs Revenue by Country (2027-2032) & (US$ Million) Table 187. Asia Pacific Calming Aids for Dogs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. Asia Pacific Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 189. Asia Pacific Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 190. Asia Pacific Calming Aids for Dogs Revenue by Country (2021-2026) & (US$ Million) Table 191. Asia Pacific Calming Aids for Dogs Revenue by Country (2027-2032) & (US$ Million) Table 192. South America Calming Aids for Dogs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 193. South America Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 194. South America Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 195. South America Calming Aids for Dogs Revenue by Country (2021-2026) & (US$ Million) Table 196. South America Calming Aids for Dogs Revenue by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Calming Aids for Dogs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 198. Middle East and Africa Calming Aids for Dogs Sales by Country (2021-2026) & (k units) Table 199. Middle East and Africa Calming Aids for Dogs Sales by Country (2027-2032) & (k units) Table 200. Middle East and Africa Calming Aids for Dogs Revenue by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Calming Aids for Dogs Revenue by Country (2027-2032) & (US$ Million) Table 202. Global Calming Aids for Dogs Sales by Type (2021-2026) & (k units) Table 203. Global Calming Aids for Dogs Sales by Type (2027-2032) & (k units) Table 204. Global Calming Aids for Dogs Sales Market Share by Type (2021-2026) Table 205. Global Calming Aids for Dogs Sales Market Share by Type (2027-2032) Table 206. Global Calming Aids for Dogs Revenue by Type (2021-2026) & (US$ Million) Table 207. Global Calming Aids for Dogs Revenue by Type (2027-2032) & (US$ Million) Table 208. Global Calming Aids for Dogs Revenue Market Share by Type (2021-2026) Table 209. Global Calming Aids for Dogs Revenue Market Share by Type (2027-2032) Table 210. Global Calming Aids for Dogs Price by Type (2021-2026) & (USD/unit) Table 211. Global Calming Aids for Dogs Price by Type (2027-2032) & (USD/unit) Table 212. Global Calming Aids for Dogs Sales by Application (2021-2026) & (k units) Table 213. Global Calming Aids for Dogs Sales by Application (2027-2032) & (k units) Table 214. Global Calming Aids for Dogs Sales Market Share by Application (2021-2026) Table 215. Global Calming Aids for Dogs Sales Market Share by Application (2027-2032) Table 216. Global Calming Aids for Dogs Revenue by Application (2021-2026) & (US$ Million) Table 217. Global Calming Aids for Dogs Revenue by Application (2027-2032) & (US$ Million) Table 218. Global Calming Aids for Dogs Revenue Market Share by Application (2021-2026) Table 219. Global Calming Aids for Dogs Revenue Market Share by Application (2027-2032) Table 220. Global Calming Aids for Dogs Price by Application (2021-2026) & (USD/unit) Table 221. Global Calming Aids for Dogs Price by Application (2027-2032) & (USD/unit) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Calming Aids for Dogs Distributors List Table 225. Calming Aids for Dogs Customers List Table 226. Calming Aids for Dogs Industry Trends Table 227. Calming Aids for Dogs Industry Drivers Table 228. Calming Aids for Dogs Industry Restraints Table 229. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Calming Aids for Dogs Product Image Figure 5. Global Calming Aids for Dogs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Calming Aids for Dogs Market Size (2021-2032) & (US$ Million) Figure 7. Global Calming Aids for Dogs Sales (2021-2032) & (k units) Figure 8. Global Calming Aids for Dogs Average Price (USD/unit) & (2021-2032) Figure 9. Calming Collars Product Image Figure 10. Calming Supplements Product Image Figure 11. Pheromone Sprays Product Image Figure 12. Anxiety Vests Product Image Figure 13. Pet Shop Product Image Figure 14. Pet Hospitals and Clinics Product Image Figure 15. Household Product Image Figure 16. Others Product Image Figure 17. Global Calming Aids for Dogs Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Calming Aids for Dogs, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Calming Aids for Dogs Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Calming Aids for Dogs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Calming Aids for Dogs Sales by Region in 2025 Figure 23. Global Calming Aids for Dogs Revenue by Region in 2025 Figure 24. North America Calming Aids for Dogs Market Size by Country in 2025 Figure 25. North America Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 26. North America Calming Aids for Dogs Revenue Market Share by Country (2021-2032) Figure 27. United States Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Calming Aids for Dogs Market Size by Country in 2025 Figure 31. Europe Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 32. Europe Calming Aids for Dogs Revenue Market Share by Country (2021-2032) Figure 33. Germany Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Calming Aids for Dogs Market Size by Country in 2025 Figure 44. Asia Pacific Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Calming Aids for Dogs Revenue Market Share by Country (2021-2032) Figure 46. China Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Calming Aids for Dogs Market Size by Country in 2025 Figure 55. South America Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 56. South America Calming Aids for Dogs Revenue Market Share by Country (2021-2032) Figure 57. Brazil Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Calming Aids for Dogs Market Size by Country in 2025 Figure 61. Middle East and Africa Calming Aids for Dogs Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Calming Aids for Dogs Revenue Market Share by Country (2021-2032) Figure 63. Egypt Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Calming Aids for Dogs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Calming Aids for Dogs Sales Market Share by Type (2021-2032) Figure 69. Global Calming Aids for Dogs Revenue Market Share by Type (2021-2032) Figure 70. Global Calming Aids for Dogs Price (USD/unit) by Type (2021-2032) Figure 71. Global Calming Aids for Dogs Sales Market Share by Application (2021-2032) Figure 72. Global Calming Aids for Dogs Revenue Market Share by Application (2021-2032) Figure 73. Global Calming Aids for Dogs Price (USD/unit) by Application (2021-2032) Figure 74. Calming Aids for Dogs Value Chain Figure 75. Calming Aids for Dogs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Calming Aids for Dogs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Calming Collars
  • Calming Supplements
  • Pheromone Sprays
  • Anxiety Vests
Applications
  • Pet Shop
  • Pet Hospitals and Clinics
  • Household
  • Others
Companies covered
  • Zoetis
  • Shangrao Chunyu Technology
  • Shandong Youmi Le Health Technology
  • Zatural
  • Wild One
  • Vetoquinol
  • ThunderEase
  • This Dog's Life
  • The Anxious Pet
  • Purina
  • Primo Pup
  • PetHonesty
  • Pet Remedy
  • Penelope's Bloom
  • NaturVet
  • Merck Animal Health
  • Maxxidog
  • Kradle
  • Koi CBD
  • King Kanine
  • Heavenly Hounds
  • FOMO Bones
  • Extract Labs
  • ElleVet Sciences
  • Elanco
  • Dr. Harvey’s
  • Ceva
  • Boehringer Ingelheim
  • Ark Naturals
  • Adaptil

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Calming Aids for Dogs Market Size (2021-2032)
  4. 2.2.2 Global Calming Aids for Dogs Sales (2021-2032)
  5. 2.2.3 Global Calming Aids for Dogs Market Average Price (2021-2032)
  6. 2.3 Calming Aids for Dogs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Calming Collars
  9. 2.3.3 Calming Supplements
  10. 2.3.4 Pheromone Sprays
  11. 2.3.5 Anxiety Vests
  12. 2.4 Calming Aids for Dogs by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Pet Shop
  15. 2.4.3 Pet Hospitals and Clinics
  16. 2.4.4 Household
  17. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Calming Aids for Dogs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Calming Aids for Dogs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Calming Aids for Dogs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Calming Aids for Dogs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Calming Aids for Dogs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Calming Aids for Dogs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Calming Aids for Dogs, Product Type & Application
  8. 3.8 Global Manufacturers of Calming Aids for Dogs, Established Date
  9. 3.9 Global Calming Aids for Dogs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Calming Aids for Dogs Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Shangrao Chunyu Technology
  8. 4.2.1 Shangrao Chunyu Technology Company Information
  9. 4.2.2 Shangrao Chunyu Technology Business Overview
  10. 4.2.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio
  12. 4.2.5 Shangrao Chunyu Technology Recent Developments
  13. 4.3 Shandong Youmi Le Health Technology
  14. 4.3.1 Shandong Youmi Le Health Technology Company Information
  15. 4.3.2 Shandong Youmi Le Health Technology Business Overview
  16. 4.3.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio
  18. 4.3.5 Shandong Youmi Le Health Technology Recent Developments
  19. 4.4 Zatural
  20. 4.4.1 Zatural Company Information
  21. 4.4.2 Zatural Business Overview
  22. 4.4.3 Zatural Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Zatural Calming Aids for Dogs Product Portfolio
  24. 4.4.5 Zatural Recent Developments
  25. 4.5 Wild One
  26. 4.5.1 Wild One Company Information
  27. 4.5.2 Wild One Business Overview
  28. 4.5.3 Wild One Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Wild One Calming Aids for Dogs Product Portfolio
  30. 4.5.5 Wild One Recent Developments
  31. 4.6 Vetoquinol
  32. 4.6.1 Vetoquinol Company Information
  33. 4.6.2 Vetoquinol Business Overview
  34. 4.6.3 Vetoquinol Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Vetoquinol Calming Aids for Dogs Product Portfolio
  36. 4.6.5 Vetoquinol Recent Developments
  37. 4.7 ThunderEase
  38. 4.7.1 ThunderEase Company Information
  39. 4.7.2 ThunderEase Business Overview
  40. 4.7.3 ThunderEase Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 ThunderEase Calming Aids for Dogs Product Portfolio
  42. 4.7.5 ThunderEase Recent Developments
  43. 4.8 This Dog's Life
  44. 4.8.1 This Dog's Life Company Information
  45. 4.8.2 This Dog's Life Business Overview
  46. 4.8.3 This Dog's Life Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 This Dog's Life Calming Aids for Dogs Product Portfolio
  48. 4.8.5 This Dog's Life Recent Developments
  49. 4.9 The Anxious Pet
  50. 4.9.1 The Anxious Pet Company Information
  51. 4.9.2 The Anxious Pet Business Overview
  52. 4.9.3 The Anxious Pet Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 The Anxious Pet Calming Aids for Dogs Product Portfolio
  54. 4.9.5 The Anxious Pet Recent Developments
  55. 4.10 Purina
  56. 4.10.1 Purina Company Information
  57. 4.10.2 Purina Business Overview
  58. 4.10.3 Purina Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Purina Calming Aids for Dogs Product Portfolio
  60. 4.10.5 Purina Recent Developments
  61. 4.11 Primo Pup
  62. 4.11.1 Primo Pup Company Information
  63. 4.11.2 Primo Pup Business Overview
  64. 4.11.3 Primo Pup Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Primo Pup Calming Aids for Dogs Product Portfolio
  66. 4.11.5 Primo Pup Recent Developments
  67. 4.12 PetHonesty
  68. 4.12.1 PetHonesty Company Information
  69. 4.12.2 PetHonesty Business Overview
  70. 4.12.3 PetHonesty Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 PetHonesty Calming Aids for Dogs Product Portfolio
  72. 4.12.5 PetHonesty Recent Developments
  73. 4.13 Pet Remedy
  74. 4.13.1 Pet Remedy Company Information
  75. 4.13.2 Pet Remedy Business Overview
  76. 4.13.3 Pet Remedy Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pet Remedy Calming Aids for Dogs Product Portfolio
  78. 4.13.5 Pet Remedy Recent Developments
  79. 4.14 Penelope's Bloom
  80. 4.14.1 Penelope's Bloom Company Information
  81. 4.14.2 Penelope's Bloom Business Overview
  82. 4.14.3 Penelope's Bloom Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Penelope's Bloom Calming Aids for Dogs Product Portfolio
  84. 4.14.5 Penelope's Bloom Recent Developments
  85. 4.15 NaturVet
  86. 4.15.1 NaturVet Company Information
  87. 4.15.2 NaturVet Business Overview
  88. 4.15.3 NaturVet Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 NaturVet Calming Aids for Dogs Product Portfolio
  90. 4.15.5 NaturVet Recent Developments
  91. 4.16 Merck Animal Health
  92. 4.16.1 Merck Animal Health Company Information
  93. 4.16.2 Merck Animal Health Business Overview
  94. 4.16.3 Merck Animal Health Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Merck Animal Health Calming Aids for Dogs Product Portfolio
  96. 4.16.5 Merck Animal Health Recent Developments
  97. 4.17 Maxxidog
  98. 4.17.1 Maxxidog Company Information
  99. 4.17.2 Maxxidog Business Overview
  100. 4.17.3 Maxxidog Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Maxxidog Calming Aids for Dogs Product Portfolio
  102. 4.17.5 Maxxidog Recent Developments
  103. 4.18 Kradle
  104. 4.18.1 Kradle Company Information
  105. 4.18.2 Kradle Business Overview
  106. 4.18.3 Kradle Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Kradle Calming Aids for Dogs Product Portfolio
  108. 4.18.5 Kradle Recent Developments
  109. 4.19 Koi CBD
  110. 4.19.1 Koi CBD Company Information
  111. 4.19.2 Koi CBD Business Overview
  112. 4.19.3 Koi CBD Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Koi CBD Calming Aids for Dogs Product Portfolio
  114. 4.19.5 Koi CBD Recent Developments
  115. 4.20 King Kanine
  116. 4.20.1 King Kanine Company Information
  117. 4.20.2 King Kanine Business Overview
  118. 4.20.3 King Kanine Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 King Kanine Calming Aids for Dogs Product Portfolio
  120. 4.20.5 King Kanine Recent Developments
  121. 4.21 Heavenly Hounds
  122. 4.21.1 Heavenly Hounds Company Information
  123. 4.21.2 Heavenly Hounds Business Overview
  124. 4.21.3 Heavenly Hounds Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Heavenly Hounds Calming Aids for Dogs Product Portfolio
  126. 4.21.5 Heavenly Hounds Recent Developments
  127. 4.22 FOMO Bones
  128. 4.22.1 FOMO Bones Company Information
  129. 4.22.2 FOMO Bones Business Overview
  130. 4.22.3 FOMO Bones Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 FOMO Bones Calming Aids for Dogs Product Portfolio
  132. 4.22.5 FOMO Bones Recent Developments
  133. 4.23 Extract Labs
  134. 4.23.1 Extract Labs Company Information
  135. 4.23.2 Extract Labs Business Overview
  136. 4.23.3 Extract Labs Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Extract Labs Calming Aids for Dogs Product Portfolio
  138. 4.23.5 Extract Labs Recent Developments
  139. 4.24 ElleVet Sciences
  140. 4.24.1 ElleVet Sciences Company Information
  141. 4.24.2 ElleVet Sciences Business Overview
  142. 4.24.3 ElleVet Sciences Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 ElleVet Sciences Calming Aids for Dogs Product Portfolio
  144. 4.24.5 ElleVet Sciences Recent Developments
  145. 4.25 Elanco
  146. 4.25.1 Elanco Company Information
  147. 4.25.2 Elanco Business Overview
  148. 4.25.3 Elanco Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Elanco Calming Aids for Dogs Product Portfolio
  150. 4.25.5 Elanco Recent Developments
  151. 4.26 Dr. Harvey’s
  152. 4.26.1 Dr. Harvey’s Company Information
  153. 4.26.2 Dr. Harvey’s Business Overview
  154. 4.26.3 Dr. Harvey’s Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Dr. Harvey’s Calming Aids for Dogs Product Portfolio
  156. 4.26.5 Dr. Harvey’s Recent Developments
  157. 4.27 Ceva
  158. 4.27.1 Ceva Company Information
  159. 4.27.2 Ceva Business Overview
  160. 4.27.3 Ceva Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Ceva Calming Aids for Dogs Product Portfolio
  162. 4.27.5 Ceva Recent Developments
  163. 4.28 Boehringer Ingelheim
  164. 4.28.1 Boehringer Ingelheim Company Information
  165. 4.28.2 Boehringer Ingelheim Business Overview
  166. 4.28.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 Boehringer Ingelheim Calming Aids for Dogs Product Portfolio
  168. 4.28.5 Boehringer Ingelheim Recent Developments
  169. 4.29 Ark Naturals
  170. 4.29.1 Ark Naturals Company Information
  171. 4.29.2 Ark Naturals Business Overview
  172. 4.29.3 Ark Naturals Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 Ark Naturals Calming Aids for Dogs Product Portfolio
  174. 4.29.5 Ark Naturals Recent Developments
  175. 4.30 Adaptil
  176. 4.30.1 Adaptil Company Information
  177. 4.30.2 Adaptil Business Overview
  178. 4.30.3 Adaptil Calming Aids for Dogs Sales, Revenue and Gross Margin (2021-2026)
  179. 4.30.4 Adaptil Calming Aids for Dogs Product Portfolio
  180. 4.30.5 Adaptil Recent Developments
5 Global Calming Aids for Dogs Market Scenario by Region
  1. 5.1 Global Calming Aids for Dogs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Calming Aids for Dogs Sales by Region: 2021-2032
  3. 5.2.1 Global Calming Aids for Dogs Sales by Region: 2021-2026
  4. 5.2.2 Global Calming Aids for Dogs Sales by Region: 2027-2032
  5. 5.3 Global Calming Aids for Dogs Revenue by Region: 2021-2032
  6. 5.3.1 Global Calming Aids for Dogs Revenue by Region: 2021-2026
  7. 5.3.2 Global Calming Aids for Dogs Revenue by Region: 2027-2032
  8. 5.4 North America Calming Aids for Dogs Market Facts & Figures by Country
  9. 5.4.1 North America Calming Aids for Dogs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Calming Aids for Dogs Sales by Country (2021-2032)
  11. 5.4.3 North America Calming Aids for Dogs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Calming Aids for Dogs Market Facts & Figures by Country
  16. 5.5.1 Europe Calming Aids for Dogs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Calming Aids for Dogs Sales by Country (2021-2032)
  18. 5.5.3 Europe Calming Aids for Dogs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Calming Aids for Dogs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Calming Aids for Dogs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Calming Aids for Dogs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Calming Aids for Dogs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Calming Aids for Dogs Market Facts & Figures by Country
  41. 5.7.1 South America Calming Aids for Dogs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Calming Aids for Dogs Sales by Country (2021-2032)
  43. 5.7.3 South America Calming Aids for Dogs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Calming Aids for Dogs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Calming Aids for Dogs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Calming Aids for Dogs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Calming Aids for Dogs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Calming Aids for Dogs Sales by Type (2021-2032)
  2. 6.1.1 Global Calming Aids for Dogs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Calming Aids for Dogs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Calming Aids for Dogs Revenue by Type (2021-2032)
  5. 6.2.1 Global Calming Aids for Dogs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Calming Aids for Dogs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Calming Aids for Dogs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Calming Aids for Dogs Sales by Application (2021-2032)
  2. 7.1.1 Global Calming Aids for Dogs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Calming Aids for Dogs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Calming Aids for Dogs Revenue by Application (2021-2032)
  5. 7.2.1 Global Calming Aids for Dogs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Calming Aids for Dogs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Calming Aids for Dogs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Calming Aids for Dogs Value Chain Analysis
  2. 8.1.1 Calming Aids for Dogs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Calming Aids for Dogs Production Mode & Process
  5. 8.2 Calming Aids for Dogs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Calming Aids for Dogs Distributors
  8. 8.2.3 Calming Aids for Dogs Customers
9 Global Calming Aids for Dogs Analyzing Market Dynamics
  1. 9.1 Calming Aids for Dogs Industry Trends
  2. 9.2 Calming Aids for Dogs Industry Drivers
  3. 9.3 Calming Aids for Dogs Industry Opportunities and Challenges
  4. 9.4 Calming Aids for Dogs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.